Skip to main content

Advertisement

Fig. 2 | Parasites & Vectors

Fig. 2

From: Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison

Fig. 2

High-transmission setting: prevalence (left) and heavy intensity infection prevalence (right) in SAC and adults during 30 years of control. a MDA targeted at the whole community (75% SAC coverage, 40% adult coverage). b Vaccination every 5 years, with a vaccine that offers 10 years protection, targeted at the community (75% SAC coverage, 40% adult coverage)

Back to article page